URGOTUL AG/Silver Plasters 10 x 12 cm

Product Information

Dumville J. C., Deshpande S., O'Meara S., Speak K. (2013a). Foam dressings for healing diabetic foot ulcers. Cochrane Database Syst. Rev. 6:CD009111 Collagen and oxidised regenerated cellulose matrix, applied directly to wound and covered with suitable dressing. Harding K., Gottrup F., Jawien A., Mikosinski J., Twardowska-Saucha K., Kaczmarek S., et al.. (2012). A prospective, multi-centre, randomised, open label, parallel, comparative study to evaluate effects of AQUACEL(R) Ag and Urgotul(R) Silver dressing on healing of chronic venous leg ulcers. Int. Wound J. 9, 285–294. 10.1111/j.1742-481X.2011.00881.x [ PMC free article] [ PubMed] [ CrossRef] [ Google Scholar] Park G. B. (1978). Burn wound coverings - a review. Biomater. Med. Devices Artif. Organs 6, 1–35. 10.3109/10731197809118690 [ PubMed] [ CrossRef] [ Google Scholar] Moore Z. E., Webster J. (2013). Dressings and topical agents for preventing pressure ulcers. Cochrane Database Syst. Rev. 8:CD009362

Norman G., Westby M. J., Rithalia A. D., Stubbs N., Soares M. O., Dumville J. C. (2018). Dressings and topical agents for treating venous leg ulcers. Cochrane Database Syst. Rev. 6:CD012583. 10.1002/14651858.CD012583.pub2 [ PMC free article] [ PubMed] [ CrossRef] [ Google Scholar] Murakami K., Aoki H., Nakamura S., Nakamura S., Takikawa M., Hanzawa M., et al.. (2010). Hydrogel blends of chitin/chitosan, fucoidan and alginate as healing-impaired wound dressings. Biomaterials 31, 83–90. 10.1016/j.biomaterials.2009.09.031 [ PubMed] [ CrossRef] [ Google Scholar] Hold secondary dressing in place with a conforming bandage, adhesive tape or an elasticated tubular bandage. Huang Y., Li X., Liao Z., Zhang G., Liu Q., Tang J., et al.. (2007). A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns 33, 161–166. 10.1016/j.burns.2006.06.020 [ PubMed] [ CrossRef] [ Google Scholar]Lazaro et al . Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer.JWC VOL 28, NO 6 , June 2019

Moore Z. E., Webster J. (2018). Dressings and topical agents for preventing pressure ulcers. Cochrane Database Syst. Rev. 12:CD009362. 10.1002/14651858.CD009362.pub3 [ PMC free article] [ PubMed] [ CrossRef] [ Google Scholar]Okuma C. H., Andrade T. A., Caetano G. F., Finci L. I., Maciel N. R., Topan J. F., et al.. (2015). Development of lamellar gel phase emulsion containing marigold oil ( Calendula officinalis) as a potential modern wound dressing. Eur. J. Pharm. Sci. 71, 62–72. 10.1016/j.ejps.2015.01.016 [ PubMed] [ CrossRef] [ Google Scholar] In the absence of specific clinical data, use in pregnant or breast-feeding women, newborn and premature babies is not recommended.

Alginate dressing, AQUACEL ® Ag dressing, Urgotul ® Silver dressing, ALLEVYN ® Hydrocellular foam dressings, Mepilex ® foam dressing Imran D., Sassoon E., Lewis D. (2004). Protection of dressings and wounds by cling film. Plast. Reconstr. Surg. 113, 1093–1094. 10.1097/01.PRS.0000107737.67371.D7 [ PubMed] [ CrossRef] [ Google Scholar] Barnea Y., Weiss J., Gur E. (2010). A review of the applications of the hydrofiber dressing with silver (Aquacel Ag) in wound care. Ther. Clin. Risk Manage. 6, 21–27. 10.2147/TCRM.S3462 [ PMC free article] [ PubMed] [ CrossRef] [ Google Scholar]

Single-use, individual and sterile dressing: re-using a single-use product may lead to risks of infection. Parpex P. et al. Management of venous leg ulcers with Cellosorb® Micro-adherent dressing: results of a multi-centre clinical trial. Phlebologie 2010; 63: 76-82. Münter KC, et al. The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings. J Wound Care. 2017 Feb; 26 (Sup2): S4-S15. Erratum in: J Wound Care. 2017 Mar 2; 26(3): 153

Nuutila K., Singh M., Kruse C., Philip J., Caterson E. J., Eriksson E. (2016). Titanium wound chambers for wound healing research. Wound Repair Regen. 24, 1097–1102. 10.1111/wrr.12472 [ PubMed] [ CrossRef] [ Google Scholar] UrgoClean has the ability to be left in place for up to 7 days, however during the early desloughing phase it may warrant more frequent dressing changes but this should be based on the clinical assessment. It is able to absorb exudate and donate fluid at the same time, dependent on the condition in different areas of the wound bed. Providing a moist wound healing environment. Hopper G. P., Deakin A. H., Crane E. O., Clarke J. (2012). Enhancing patient recovery following lower limb arthroplasty with a modern wound dressing: a prospective, comparative audit. J. Wound Care 21, 200–203. 10.12968/jowc.2012.21.4.200 [ PubMed] [ CrossRef] [ Google Scholar] Guo S., Dipietro L. A. (2010). Factors affecting wound healing. J. Dent. Res. 89, 219–229. 10.1177/0022034509359125 [ PMC free article] [ PubMed] [ CrossRef] [ Google Scholar]CAV III: in non-infected (IDSA/IWGDF infection criteria) neuro-ischaemic diabetic foot ulcers (non-critical ischaemia), in the granulation phase (sequential treatment). Foam dressing, hydrocolloids dressing, multi-layered soft silicone foam dressings, polyurethane film, Mepilex ® Ag dressing, polyurethane foam dressing If an antiseptic has been used previously, carefully rinse the wound with normal saline before applying UrgoTul Absorb. Medihoney Gel Sheet is a sterile, non-adherent wound dressing made from Medihoney Antibacterial Honey (80%w/w) and Sodium Alginate for wound care (20%w/w).